Displaying 1 - 12 of 89
Immune-Mediated and Cholestatic Diseases

Gilead: Creating change today: Lowering risk, lowering burden of PBC in practice (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Gilead: Creating change today: Lowering risk, lowering burden of PBC (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Medscape Education Global: Primary Biliary Cholangitis: Setting Higher Expectations (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

AKH Inc., Advancing Knowledge in Healthcare: A New Era in MASH: How Disease-Specific Therapies Are Changing the Game and Best ...

Webcasts
View
Immune-Mediated and Cholestatic Diseases

IPSEN: Nuances in treatment decisions for PBC management (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Amgen: Mitigating the Impact of IgG4-Related Cholangitis (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

Novo Nordisk: Updates on the essence of MASH (Complete Session)

Webcasts
View
Viral Hepatitis

Gilead: AChievaBle toDay: For all patients with viral hepatitis (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Mirum: Meet the Experts in Cholestatic Liver Disease (Complete Session)

Webcasts
View
General Hepatology

Takeda: The alpha-1 antitrypsin deficiency liver care journey: From early signs to effective strategies (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Mirum: Adult Cholestatic Liver Disease: Focusing on Clinical Outcomes and the Future of IBAT Inhibitors (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

Opella: MASLD's impact on metabolic health and quality of life – new evidence (Complete Session)

Webcasts
View
Displaying 1 - 12 of 89